BTIG Downgrades Intersect ENT (XENT) to Neutral, Following Acquisition

August 9, 2021 4:19 PM EDT
Get Alerts XENT Hot Sheet
Price: $26.94 --0%

Rating Summary:
    4 Buy, 9 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 16 | Down: 18 | New: 32
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

BTIG analyst Ryan Zimmerman downgraded Intersect ENT (NASDAQ: XENT) from Buy to Neutral.

For an analyst ratings summary and ratings history on Intersect ENT click here. For more ratings news on Intersect ENT click here.

Shares of Intersect ENT closed at $27.37 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

BTIG